Asterand

• 

  30/11/11

  Asterand’s shares up almost 10 per cent after “research milestone” achieved

  The company announced this morning that its BioSeek subsidiary has achieved a research milestone in a drug discovery collaboration with Japan’s Ono Pharmaceutical

• 

  17/12/10

  The quiet revolution that promises to transform Asterand

  Martyn Coombs, boss of the tissue science specialist, reveals there is a quiet revolution taking place at Asterand. Perhaps this explains why the hedge fund Inflection Point decided to build a stake in the group.

• 

  08/10/10

  Asterand's Coombs says NCI supply contract will make a 'material difference' to business

  Asterand filled us in on the details of company's ground-breaking deal with America’s National Cancer Institute during a conference call with analysts. Here is what boss Martyn Coombs had to say.

• 

  01/10/10

  Asterand shares soar on major contract win

  The five-year contract is worth up to US$24.3 million. The deal provides a major boost for the tissue supply business, which has been squeezed as the economic downturn hit 'Big-Pharma' R&D spending.

• 

  26/08/10

  Asterand 'has weathered the worst of the storm'

  Chief Excutive Martyn Coombs believes the company has weathered the worst of the storm in the contract research market, and analyst forecasts see Asterand making up lost ground in the second half.

   

• 

  19/04/10

  Asterand: investing for the future

  The group is looking ahead with optimism as human tissue testing is becoming mission critical to the pharmaceutical industry. Asterand is well placed in a market that is growing.

• 

  18/02/10

  Asterand completes BioSeek acquisition marking first step in ‘buy-and-build’ strategy

  Asterand announced its plan to buy the privately-held BioSeek for up to US$14 million in cash and shares, back in November 2009.

• 

  18/11/09

  Asterand to buy US drug discovery services group BioSeek, 9 mths trading ‘encouraging’

  Asterand PLC (LSE: ATD) reported encouraging trading for the first nine months and announced it plans to buy privately-held US drug discovery services company BioSeek Inc for up to US$14 million in cash and shares.

• 

  17/12/08

  Asterand – on the cusp of profitability

  Asterand is a healthcare services business that supplies human tissue and tissue-based research services to drug discovery organisations.
• 

  11/11/08

  Asterand says revenue growth even stronger in third quarter

Connect with Facebook to view or add comments for this company